The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Jeffrey V Lazarus,Hannah Han,Henry E Mark,Saleh A Alqahtani,Jörn M Schattenberg,Joan B Soriano,Trenton M White,Shira Zelber-Sagi,M Ashworth Dirac,GBD Fatty Liver Disease Sustainable Development Goal Collaborators,Amirali Aali,Mohsen Abbasi-Kangevari,Eman Abu-Gharbieh,Osama Abu-Shawer,Manik Aggarwal,Bright Opoku Ahinkorah,Aqeel Ahmad,Ali Ahmadi,Fares Alahdab,Motasem Alkhayyat,Sami Almustanyir,Hubert Amu,Amir Anoushiravani,Tahira Ashraf,Bantalem Tilaye Tilaye Atinafu,Sina Azadnajafabad,Nayereh Baghcheghi,Sara Bagherieh,Mainak Bardhan,Diana Fernanda Bejarano Ramirez,Akshaya Srikanth Bhagavathula,Neeraj Bhala,Ajay Nagesh Bhat,Mariah Malak Bilalaga,Antonio Biondi,Saeid Bitaraf,Srinivasa Rao Bolla,Antoine Boustany,Daniela Calina,Ismael R Campos-Nonato,Kumar Chattu Vijay,Sheng-Chia Chung,Daniela Contreras,Sandra Cortés,Omar B Da'ar,Omid Dadras,Xiaochen Dai,Bardia Danaei,Rupak Desai,Shirin Djalalinia,Deepa Dongarwar,Haneil Larson Dsouza,Temitope Cyrus Ekundayo,Iman El Sayed,Noha Mousaad Elemam,Mohamed A Elmonem,Aisha Elsharkawy,Sayeh Ezzikouri,Amr Farwati,Farshad Farzadfar,Ginenus Fekadu,Florian Fischer,Tushar Garg,Elena S George,Seyyed-Hadi Ghamari,Mohammad Ghasemi Nour,Amit Goel,Mahaveer Golechha,Pouya Goleij,Vivek Kumar Gupta,Parham Habibzadeh,Adel Hajj Ali,Saeed S Hamid,Harapan Harapan,Sanam Hariri,Maryam Hashemian,Abbas M Hassan,Mohammed Bheser Hassen,Simon I Hay,Yuta Hiraike,Reza Homayounfar,Mohammad-Salar Hosseini,Sedighe Hosseini Shabanan,Soodabeh Hoveidamanesh,Vivian Chia-Rong Hsieh,Junjie Huang,Salman Hussain,Segun Emmanuel Ibitoye,Olayinka Stephen Ilesanmi,Nahlah Elkudssiah Ismail,Chidozie Cd Iwu,J Linda Merin,Elham Jamshidi,Umesh Jayarajah,Shubha Jayaram,Bijay ghMukesh Jeswani,Jost B Jonas,Abel Joseph,Charity Ehimwenma Joshua,Jacek Jerzy Jozwiak,Ali Kabir,Vidya Kadashetti,Tesfaye K Kanko,Rami S Kantar,Nitin Kapoor,Ibraheem M Karaye,Joonas H Kauppila,Mohammad Keykhaei,Moien A B Khan,Min Seo Kim,Hamid Reza Koohestani,Ambily Kuttikkattu,Carlo La Vecchia,Bagher Larijani,Sang-Woong Lee,Yeong Yeh Lee,Lee-Ling Lim,Stephen S Lim,Chun-Han Lo,Stefan Lorkowski,Jamal Majidpoor,Mohammad-Reza Malekpour,Yasaman Mansoori,Miquel Martorell,Sahar Masoudi,Alexios-Fotios A Mentis,Tuomo J Meretoja,Tomislav Mestrovic,Erkin M Mirrakhimov,Awoke Misganaw,Abdollah Mohammadian-Hafshejani,Ali H Mokdad,Jibran Sualeh Muhammad,Efrén Murillo-Zamora,Christopher J L Murray,Mukhammad David Naimzada,Sreenivas Narasimha Swamy,Hasan Nassereldine,Zuhair S Natto,Robina Khan Niazi,Virginia Nuñez-Samudio,Bogdan Oancea,In-Hwan Oh,Olubunmi Omotola Oladunjoye,Antonio Olivas-Martinez,Jagadish Rao Padubidri,Beng Seoyeon Park,Harsh K Patel,Ronit Patnaik Patnaik,Venkata Suresh Patthipati,Gayatri Pemmasani,Simone Perna,Vivek Podder,Akram Pourshams,Akila Prashant,Pradhum Ram,Indu Ramachandra Rao,Sina Rashedi,Mohammad-Mahdi Rashidi,Negar Rezaei,Jefferson Antonio Buendia Rodriguez,Leonardo Roever,Gholamreza Roshandel,Bahar Saberzadeh-Ardestani,Umar Saeed,Sher Zaman Safi,Amirhossein Sahebkar,Soumya Swaroop Sahoo,Mohammad Amin Salehi,Abdallah M Samy,Senthilkumar Sankararaman,Chinmoy Sarkar,Danish Iltaf Satti,Allen Seylani,Pritik A Shah,Elaheh Shaker,Ali Shamekh,Parnian Shobeiri,Seyed Afshin Shorofi,Jasvinder A Singh,Paramdeep Singh,Md Shahjahan Siraj,Anna Aleksandrovna Skryabina,Amir Ali Sohrabpour,Keita Suzuki,Majid Taheri,Ker-Kan Tan,Samar Tharwat,Nikhil Kenny Thomas,Bereket M Tigabu,Marco Vacante,Seyed Mohammad Vahabi,Rohollah Valizadeh,Tommi Juhani Vasankari,Theo Vos,Cong Wang,Song Wang,Nuwan Darshana Wickramasinghe,Suowen Xu,Chuanhua Yu,Ismaeel Yunusa,Mazyar Zahir,Moein Zangiabadian,Zhi-Jiang Zhang

DOI: https://doi.org/10.1097/HEP.0000000000000361

IF: 17.298

2023-09-01

Hepatology

Abstract:Background and aims: Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. Approach and results: We developed 2 fatty liver disease-SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease-SDG score, indicators were categorized as "positive" or "negative" and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease-SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored > 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease-SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. Conclusions: The fatty liver disease-SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.